HeMemics Overview

  • Year Founded
  • 2007

Year Founded

  • Status
  • Private

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Seed

  • Latest Deal Amount
  • $4.5M

  • Investors
  • 6

HeMemics General Information

Description

Developer of a graphene-based biosensor platform designed to bring handheld, lab-quality testing performance wherever needed. The company's platform offers a revolutionary testing platform that achieves (Polymerase chain reaction) PCR-level accuracy while maintaining the cost-effectiveness of lateral-flow tests and allows for the simultaneous testing of antibodies, antigens, and molecular targets, encompasses a robust, battery-operated handheld reader and a disposable biosensor, thereby enabling clients with the tools required for prompt and informed decision-making, fostering a safer, healthier world.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Biotechnology
Diagnostic Equipment
Corporate Office
  • 401 Professional Drive
  • Suite 220
  • Gaithersburg, MD 20879-3445
  • United States
+1 (240) 000-0000

HeMemics Timeline

2021202220232024
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

HeMemics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
10. Seed Round 05-Sep-2023 $4.5M 00.00 Completed Product Development
9. Seed Round 25-May-2023 00.00 00.000 Completed Product Development
8. Secondary Transaction - Private 00.000 Completed Product Development
7. Seed Round 31-Dec-2020 00.000 00.000 00.000 Completed Product Development
6. Seed Round 09-Nov-2018 00000 00000 00.000 Completed Product Development
5. Angel (individual) 25-May-2018 00000 00000 Completed Startup
4. Seed Round 18-Dec-2017 0000 00000 Completed Startup
3. Accelerator/Incubator 01-Dec-2017 00000 Completed Startup
2. Grant 01-Jan-2012 $185K $107K Completed Startup
1. Accelerator/Incubator 13-Aug-2007 $107K $107K Completed Startup
To view HeMemics’s complete valuation and funding history, request access »

HeMemics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Seed 2 00,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
Seed 1 0,000,000 00.000000 00.00 00.00 00 00.00 0.000
To view HeMemics’s complete cap table history, request access »

HeMemics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of a graphene-based biosensor platform designed to bring handheld, lab-quality testing performance wherever ne
Other Healthcare Technology Systems
Gaithersburg, MD
8 As of 2023
00.00
000000000 00.00

0000 0

bore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation
0000000000 000000000
Saint Paul, MN
0 As of 0000
000.00
0000000000 0 000.00

00-00

sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labo
0000 000000000
Salt Lake City, UT
000 As of 0000
00.000
000000 - 000 00.000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

HeMemics Competitors (5)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Grip Molecular Venture Capital-Backed Saint Paul, MN 0 000.00 0000000000 0 000.00
Co-Dx Formerly VC-backed Salt Lake City, UT 000 00.000 000000 - 000 00.000
GrapheneDx Private Equity-Backed Boston, MA 00 0000000 0000
Lucira Health Formerly VC-backed Emeryville, CA 000 00000 000000&0
Cardea Formerly VC-backed San Diego, CA 00 000.00 000000&0 000.00
You’re viewing 5 of 5 competitors. Get the full list »

HeMemics Patents

HeMemics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-4150331-A1 Multiplex biosensor for rapid point-of-care diagnostics Pending 15-May-2020 0000000000
US-20230194520-A1 Multiplex biosensor for rapid point-of-care diagnostics Pending 15-May-2020 0000000000
EP-4150331-A4 Multiplex biosensor for rapid point-of-care diagnostics Pending 15-May-2020 0000000000 0
US-20210389272-A1 Biosensors using carbon nanotubes and an electronic reader for use with the biosensors Pending 05-Oct-2018 00000000000 0
EP-3861330-A1 Biosensors using carbon nanotubes and an electronic reader for use with the biosensors Inactive 05-Oct-2018 G01N27/4146
To view HeMemics’s complete patent history, request access »

HeMemics Executive Team (10)

Name Title Board Seat Contact Info
David Ho Ph.D Co-Founder, CSO, President & Board Member
Richard Liu Chief Financial Officer
John Warden Jr. Co-Founder, Chief Executive Officer and Chairman of the Board
Valerie Vo Chief Investment Officer
You’re viewing 4 of 10 executive team members. Get the full list »

HeMemics Board Members (14)

Name Representing Role Since
David Ho Ph.D HeMemics Co-Founder, CSO, President & Board Member 000 0000
Hao Nguyen Self Board Member 000 0000
Hoa Nguyen Ph.D Self Board Member 000 0000
John Warden Jr. HeMemics Co-Founder, Chief Executive Officer and Chairman of the Board 000 0000
Katherine Hill Ritchie TEDCO Board Observer 000 0000
You’re viewing 5 of 14 board members. Get the full list »

HeMemics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

HeMemics Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
American Vietnamese Investment Partners Venture Capital Minority 000 0000 000000 0
Inova Strategic Investments Corporate Venture Capital Minority 000 0000 000000 0
Inova Health System Corporation Minority 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
Maryland Industrial Partnerships University Minority 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

HeMemics FAQs

  • When was HeMemics founded?

    HeMemics was founded in 2007.

  • Who is the founder of HeMemics?

    David Ho Ph.D, John Warden Jr., and Stephen Bruttig Ph.D are the founders of HeMemics.

  • Who is the CEO of HeMemics?

    John Warden Jr. is the CEO of HeMemics.

  • Where is HeMemics headquartered?

    HeMemics is headquartered in Gaithersburg, MD.

  • What is the size of HeMemics?

    HeMemics has 8 total employees.

  • What industry is HeMemics in?

    HeMemics’s primary industry is Other Healthcare Technology Systems.

  • Is HeMemics a private or public company?

    HeMemics is a Private company.

  • What is HeMemics’s current revenue?

    The current revenue for HeMemics is 00000.

  • How much funding has HeMemics raised over time?

    HeMemics has raised $9.5M.

  • Who are HeMemics’s investors?

    American Vietnamese Investment Partners, Inova Strategic Investments, Inova Health System, U.S. Department of Health and Human Services, and Maryland Industrial Partnerships are 5 of 6 investors who have invested in HeMemics.

  • Who are HeMemics’s competitors?

    Grip Molecular, Co-Dx, GrapheneDx, Lucira Health, and Cardea are competitors of HeMemics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »